Disease Management and Treatment of Chronic Myeloid Leukemia (CML): Experience From the Patient (Pt) Perspective.

Journal of Clinical Oncology - United States
doi 10.1200/jco.2011.29.15_suppl.6606
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

PSY12 the Cost of Treating Chronic Myeloid Leukemia (CML) in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Current Patient Management of Chronic Myeloid Leukemia in Latin America

Cancer
Cancer ResearchOncology
2010English

Considerations for Treatment-Free Remission in Patients With Chronic Myeloid Leukemia: A Joint Patient-Physician Perspective

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2018English

Treatment-Related Acute Myeloid Leukemia in a Chronic Lymphocytic Leukemia Patient: Role of Fludarabine?

Therapeutic Advances in Hematology
Hematology
2015English

Leukemia Cutis in a Patient With Chronic Myeloid Leukemia

IOSR Journal of Dental and Medical Sciences
2014English

Study to Assess the Pathophysiological Role of VEGF in Patients With Chronic Myeloid Leukemia(CML)

International Journal of Medical Science and Public Health
2013English

Management of Chronic Myeloid Leukemia in Advanced Phase

Frontiers in Oncology
Cancer ResearchOncology
2019English

Concamitant Expression of the Rare E1/A3 and B2/A3 Types of BCR/ABL Transcript in a Chronic Myeloid Leukemia (CML) Patient

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1999English

Cost-Utility Analysis of Bosutinib for Previously Treated Chronic Myeloid Leukemia (Cml) in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy